Progression-Free Survival Increased With Zanubrutinib in Leukemia
Longer progression-free survival seen with zanubrutinib versus ibrutinib for patients with relapsed or refractory chronic or small lymphocytic leukemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.